Risk factors for excessive gestational weight gain in a UK population: a biopsychosocial model approach.


Journal

BMC pregnancy and childbirth
ISSN: 1471-2393
Titre abrégé: BMC Pregnancy Childbirth
Pays: England
ID NLM: 100967799

Informations de publication

Date de publication:
10 Jan 2021
Historique:
received: 06 03 2020
accepted: 22 12 2020
entrez: 11 1 2021
pubmed: 12 1 2021
medline: 18 5 2021
Statut: epublish

Résumé

Gestational weight gain (GWG) can have implications for the health of both mother and child. However, the contributing factors remain unclear. Despite the advantages of using a biopsychosocial approach, this approach has not been applied to study GWG in the UK. This study aimed to investigate the risk factors of excessive GWG in a UK population, employing a biopsychosocial model. This study utilised data from the longitudinal Grown in Wales (GiW) cohort, which recruited women in late pregnancy in South Wales. Specifically, data was collected from midwife recorded notes and an extensive questionnaire completed prior to an elective caesarean section (ELCS) delivery. GWG was categorised according to Institute of Medicine (IOM) guidelines. The analysis was undertaken for 275 participants. In this population 56.0% of women had excessive GWG. Increased prenatal depression symptoms (Exp(B)=1.10, p=.019) and an overweight (Exp(B)=4.16, p<.001) or obese (Exp(B)=4.20, p=.010) pre-pregnancy BMI, consuming alcohol in pregnancy (Exp(B)=.37, p=.005) and an income of less than £18,000 (Exp(B)=.24, p=.043) and £25-43,000 (Exp(B)=.25, p=.002) were associated with excessive GWG. GWG is complex and influenced by a range of biopsychosocial factors, with the high prevalence of excessive weight gain in this population a cause for concern. Women in the UK may benefit from a revised approach toward GWG within the National Health Service (NHS), such as tracking weight gain throughout pregnancy. Additionally, this research provides evidence for potential targets for future interventions, and potentially at-risk populations to target, to improve GWG outcomes.

Sections du résumé

BACKGROUND BACKGROUND
Gestational weight gain (GWG) can have implications for the health of both mother and child. However, the contributing factors remain unclear. Despite the advantages of using a biopsychosocial approach, this approach has not been applied to study GWG in the UK. This study aimed to investigate the risk factors of excessive GWG in a UK population, employing a biopsychosocial model.
METHODS METHODS
This study utilised data from the longitudinal Grown in Wales (GiW) cohort, which recruited women in late pregnancy in South Wales. Specifically, data was collected from midwife recorded notes and an extensive questionnaire completed prior to an elective caesarean section (ELCS) delivery. GWG was categorised according to Institute of Medicine (IOM) guidelines. The analysis was undertaken for 275 participants.
RESULTS RESULTS
In this population 56.0% of women had excessive GWG. Increased prenatal depression symptoms (Exp(B)=1.10, p=.019) and an overweight (Exp(B)=4.16, p<.001) or obese (Exp(B)=4.20, p=.010) pre-pregnancy BMI, consuming alcohol in pregnancy (Exp(B)=.37, p=.005) and an income of less than £18,000 (Exp(B)=.24, p=.043) and £25-43,000 (Exp(B)=.25, p=.002) were associated with excessive GWG.
CONCLUSION CONCLUSIONS
GWG is complex and influenced by a range of biopsychosocial factors, with the high prevalence of excessive weight gain in this population a cause for concern. Women in the UK may benefit from a revised approach toward GWG within the National Health Service (NHS), such as tracking weight gain throughout pregnancy. Additionally, this research provides evidence for potential targets for future interventions, and potentially at-risk populations to target, to improve GWG outcomes.

Identifiants

pubmed: 33423656
doi: 10.1186/s12884-020-03519-1
pii: 10.1186/s12884-020-03519-1
pmc: PMC7798251
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

43

Subventions

Organisme : Medical Research Council
ID : MR/M013960/1
Pays : United Kingdom
Organisme : Biotechnology and Biological Sciences Research Council
ID : BB/M009122/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/N013794/1
Pays : United Kingdom

Références

BMC Pregnancy Childbirth. 2017 Sep 7;17(1):296
pubmed: 28882122
Health Care Women Int. 2017 Aug;38(8):892-904
pubmed: 28524735
Arch Gynecol Obstet. 2014 Feb;289(2):247-57
pubmed: 24141389
BJPsych Open. 2018 Aug 17;4(5):354-360
pubmed: 30202597
Obstet Med. 2020 Jun;13(2):55-61
pubmed: 32714436
Matern Child Health J. 2014 May;18(4):1038-47
pubmed: 24077985
PLoS One. 2019 Mar 12;14(3):e0213412
pubmed: 30861017
J Affect Disord. 2015 May 1;176:95-105
pubmed: 25704562
Br J Psychiatry. 1987 Jun;150:782-6
pubmed: 3651732
JAMA. 2017 Jun 6;317(21):2207-2225
pubmed: 28586887
Br J Psychiatry. 1985 Mar;146:287-93
pubmed: 3986438
Matern Child Health J. 2012 Apr;16(3):668-76
pubmed: 21431862
JAMA. 2019 May 7;321(17):1702-1715
pubmed: 31063572
BMC Pregnancy Childbirth. 2019 Sep 2;19(1):322
pubmed: 31477075
Pediatrics. 2011 Apr;127(4):e948-55
pubmed: 21402626
J Affect Disord. 2011 Sep;133(1-2):1-15
pubmed: 21078523
Obesity (Silver Spring). 2008 Jul;16(7):1657-66
pubmed: 18451771
Am J Obstet Gynecol. 2009 Oct;201(4):339.e1-14
pubmed: 19788965
J Affect Disord. 2008 May;108(1-2):101-11
pubmed: 18001841
Int J Gynaecol Obstet. 2005 Nov;91(2):125-31
pubmed: 16202415
J Neonatal Perinatal Med. 2019;12(2):179-187
pubmed: 30584173
J Obstet Gynaecol Can. 2009 Jan;31(1):28-35
pubmed: 19208280
Arch Womens Ment Health. 2006 Nov;9(6):309-15
pubmed: 17013761
J Matern Fetal Neonatal Med. 2016 Nov;29(21):3527-31
pubmed: 26742688
Cad Saude Publica. 2014 Mar;30(3):633-44
pubmed: 24714952
Sex Reprod Healthc. 2011 Jan;2(1):43-8
pubmed: 21147458
Pediatr Obes. 2013 Jun;8(3):218-24
pubmed: 23172639
BJOG. 2019 Jul;126(8):984-995
pubmed: 30786138
Public Health Nutr. 2015 Jun;18(8):1488-98
pubmed: 25171690
J Health Psychol. 2020 Apr 17;:1359105320913934
pubmed: 32301343

Auteurs

S M Garay (SM)

Biomedicine Division, School of Biosciences, Cardiff University, Cardiff, CF10 3AX, UK.

L A Sumption (LA)

Biomedicine Division, School of Biosciences, Cardiff University, Cardiff, CF10 3AX, UK.

R M Pearson (RM)

Centre for Academic Mental Health, Population Health Sciences, Bristol Medical School, University of Bristol, Oakfield House, Bristol, BS8 2BN, UK.

R M John (RM)

Biomedicine Division, School of Biosciences, Cardiff University, Cardiff, CF10 3AX, UK. JohnRM@cf.ac.uk.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH